TOP TEN Passage Bio
TOP TEN Passage Bio
CEO : Bruce Goldsmith
02
Passage Bio , a genetic medicines company that develops transformative therapies for the treatment of rare monogenic central nervous system ( CNS ) disorders . Putting patients at the centre of every decision made , its vision is to become the premier genetic medicines company that dramatically and positively transforms the lives of patients .
To achieve this , Passage Bio is in collaboration with the University of Pennsylvania ’ s Gene Therapy Program ( GTP ), gaining access to cutting edge capabilities and innovation in genetic medicine research .
Passage Bio has three lead product candidates , as well as three ongoing discovery programs , and options to license eleven additional programs from the GTP . Passage Bio purposefully focuses on rare , monogenic CNS as it believes its genetic medicine approach provides “ distinct technical advantages based on decades of research by GTP .”
“Passage Bio purposefully focuses on rare , monogenic CNS ”
technologymagazine . com 155